Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Issue Archive

Table of Contents

INSIDE BLOOD

GENE THERAPY
CLINICAL OBSERVATIONS
HEMOSTASIS
IMMUNOBIOLOGY
NEOPLASIA
IMMUNOBIOLOGY
NEOPLASIA
HEMATOPOIESIS
TRANSPLANTATION
HEMOSTASIS
RED CELLS

PLENARY PAPERS

ERRATUM

REVIEW ARTICLES

REVIEW IN TRANSLATIONAL HEMATOLOGY

HOW I TREAT

CHEMOKINES, CYTOKINES, AND INTERLEUKINS

CLINICAL TRIALS AND OBSERVATIONS

Jean-Luc Harousseau,for the Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group,Jeffrey E. Lancet,for the Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group,Josy Reiffers,for the Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group,Bob Lowenberg,for the Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group,Xavier Thomas,for the Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group,Francoise Huguet,for the Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group,Pierre Fenaux,for the Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group,Steven Zhang,for the Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group,Wayne Rackoff,for the Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group,Peter De Porre,for the Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group,Richard Stone,for the Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group

GENE THERAPY

HEMATOPOIESIS

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY

IMMUNOBIOLOGY

NEOPLASIA

RED CELLS

STEM CELLS IN HEMATOLOGY

TRANSPLANTATION

CORRESPONDENCE

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals